Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pediatr ; 108(4): 558-61, 1986 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3958828

RESUMO

To study the antioxidant effect of high-dose vitamin E alone and in combination with selenium in patients with glucose-6-phosphate dehydrogenase deficiency with mild chronic hemolysis, 36 male children with such manifestations were enrolled consecutively into two equal groups. Group 1 received 800 IU vitamin E daily, and group 2 received 800 IU vitamin E in combination with 25 micrograms selenium. Hematologic status before and 2 months after treatment was evaluated. After treatment there was a significant change toward normal in both groups. The mean red cell half-life increased in group 1 from 16.9 to 22.8 days (P less than 0.01), and in group 2 from 15.6 to 24.3 days (P less than 0.01). A comparison of the mean difference of paired values in the two groups revealed a more significant increase in hemoglobin (0.9 +/- 0.1 gm/dl vs 1.2 +/- 0.2 gm/dl, P less than 0.05), hematocrit (2.4% +/- 0.4% vs 3.8% +/- 0.3%, P less than 0.05), and red cell half-life (5.9 +/- 3.0 days vs 9.1 +/- 4.4 days, P less than 0.01), and more significant reduction in reticulocytes (-0.7% +/- 0.2% vs -1.5% +/- 0.4%, P less than 0.01) in group 2. Clinical assessment and follow-up indicated no side effects related to the drugs.


Assuntos
Envelhecimento Eritrocítico/efeitos dos fármacos , Deficiência de Glucosefosfato Desidrogenase/sangue , Hemólise/efeitos dos fármacos , Selênio/administração & dosagem , Vitamina E/administração & dosagem , Adolescente , Criança , Pré-Escolar , Quimioterapia Combinada , Contagem de Eritrócitos/efeitos dos fármacos , Seguimentos , Deficiência de Glucosefosfato Desidrogenase/tratamento farmacológico , Meia-Vida , Hematócrito , Hemoglobinas/análise , Humanos , Masculino , Reticulócitos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA